Mice with class II negative cDC1 show weak expansion of antigen-specific CD8+ cells and fail to reject tumors, indicating that class II on cDC1 (the paradigmatic professional APC) is required to mediate tumor regression (20). This evidence concerns the gene MPPE1 and neoplasm.